Postprandial lipoprotein (a) response to a single meal containing either saturated or ω-3 polyunsaturated fatty acids in subjects with hypoalphalipoproteinemia-Reference-Cited by-同舟云学术

Postprandial lipoprotein (a) response to a single meal containing either saturated or ω-3 polyunsaturated fatty acids in subjects with hypoalphalipoproteinemia

Published:1992-12 Issue:12 Volume:41 Page:1361-1366
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Scanu Angelo M.,Edelstein Celina,Fless Gunther M.,Eisenbart James,Sitrin Michael,Kasawa Bahaa,Hinman Janet

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference19 articles.

1. The mysteries of lipoprotein(a);Utermann;Science,1989

2. Lipoprotein(a): Heterogeneity and biological relevance;Scanu;J Clin Invest,1990

3. Lipoprotein(a): A genetically determined cardiovascular pathogen in search of a function;Scanu;J Lab Clin Med,1990

4. Fat feeding in humans induces lipoproteins of density less than 1.006 g/ml that are enriched in apolipoprotein(a) and that cause lipid accumulation in macrophages;Bersot;J Clin Invest,1986

5. Solubility, immunochemical, and lipoprotein binding properties of apoB100-apo(a), the protein moiety of lipoprotein(a);Fless;J Lipid Res,1990

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Omega-3 polyunsaturated fatty acid profiling using fingertip-prick whole blood does not require overnight fasting before blood collection;Nutrition Research;2012-08

2. PPARαL162V polymorphism alters the potential of n-3 fatty acids to increase lipoprotein lipase activity;Molecular Nutrition & Food Research;2009-11-24

3. Postprandial Lipaemia, Haemostasis, Inflammatory Response and other Emerging Risk Factors for Cardiovascular Disease: The Influence of Fatty Meals;Current Nutrition & Food Science;2005-01-01

4. Postprandial Lipoprotein(a) Is Affected Differently by Specific Individual Dietary Fatty Acids in Healthy Young Men;The Journal of Nutrition;2004-10-01

5. Xuezhikang Decreases Serum Lipoprotein(a) and C-reactive Protein Concentrations in Patients with Coronary Heart Disease;Clinical Chemistry;2003-08-01